Fig. 5.
Immunohistochemical observation of full-thickness wound at 4 days. The immunoactive area of TGF-β1 (brown) is markedly increased in the control group, especially in the stroma (A, C). The expression of TGF-β1 was decreased in the EGF-treated group (B, E) but increased in the adjacent normal skin area (D).